Cargando…

A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells

CBL-family ubiquitin ligases are critical negative regulators of tyrosine kinase signaling, with a clear redundancy between CBL and CBL-B evident in the immune cell and hematopoietic stem cell studies. Since CBL and CBL-B are negative regulators of immune cell activation, elimination of their functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetz, Benjamin, An, Wei, Mohapatra, Bhopal, Zutshi, Neha, Iseka, Fany, Storck, Matthew D., Meza, Jane, Sheinin, Yuri, Band, Vimla, Band, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239462/
https://www.ncbi.nlm.nih.gov/pubmed/27276677
http://dx.doi.org/10.18632/oncotarget.9812
_version_ 1782495898969833472
author Goetz, Benjamin
An, Wei
Mohapatra, Bhopal
Zutshi, Neha
Iseka, Fany
Storck, Matthew D.
Meza, Jane
Sheinin, Yuri
Band, Vimla
Band, Hamid
author_facet Goetz, Benjamin
An, Wei
Mohapatra, Bhopal
Zutshi, Neha
Iseka, Fany
Storck, Matthew D.
Meza, Jane
Sheinin, Yuri
Band, Vimla
Band, Hamid
author_sort Goetz, Benjamin
collection PubMed
description CBL-family ubiquitin ligases are critical negative regulators of tyrosine kinase signaling, with a clear redundancy between CBL and CBL-B evident in the immune cell and hematopoietic stem cell studies. Since CBL and CBL-B are negative regulators of immune cell activation, elimination of their function to boost immune cell activities could be beneficial in tumor immunotherapy. However, mutations of CBL are associated with human leukemias, pointing to tumor suppressor roles of CBL proteins; hence, it is critical to assess the tumor-intrinsic roles of CBL and CBL-B in cancers. This has not been possible since the only available whole-body CBL-B knockout mice exhibit constitutive tumor rejection. We engineered a new CBL-B(flox/flox) mouse, combined this with an existing CBL(flox/flox) mouse to generate CBL(flox/flox); CBL-B(flox/flox) mice, and tested the tissue-specific concurrent deletion of CBL and CBL-B using the widely-used CD4-Cre transgenic allele to produce a T-cell-specific double knockout. Altered T-cell development, constitutive peripheral T-cell activation, and a lethal multi-organ immune infiltration phenotype largely resembling the previous Lck-Cre driven floxed-CBL deletion on a CBL-B knockout background establish the usefulness of the new model for tissue-specific CBL/CBL-B deletion. Unexpectedly, CD4-Cre-induced deletion in a small fraction of hematopoietic stem cells led to expansion of certain non-T-cell lineages, suggesting caution in the use of CD4-Cre for T-cell-restricted gene deletion. The establishment of a new model of concurrent tissue-selective CBL/CBL-B deletion should allow a clear assessment of the tumor-intrinsic roles of CBL/CBL-B in non-myeloid malignancies and help test the potential for CBL/CBL-B inactivation in immunotherapy of tumors.
format Online
Article
Text
id pubmed-5239462
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-52394622017-01-24 A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells Goetz, Benjamin An, Wei Mohapatra, Bhopal Zutshi, Neha Iseka, Fany Storck, Matthew D. Meza, Jane Sheinin, Yuri Band, Vimla Band, Hamid Oncotarget Research Paper CBL-family ubiquitin ligases are critical negative regulators of tyrosine kinase signaling, with a clear redundancy between CBL and CBL-B evident in the immune cell and hematopoietic stem cell studies. Since CBL and CBL-B are negative regulators of immune cell activation, elimination of their function to boost immune cell activities could be beneficial in tumor immunotherapy. However, mutations of CBL are associated with human leukemias, pointing to tumor suppressor roles of CBL proteins; hence, it is critical to assess the tumor-intrinsic roles of CBL and CBL-B in cancers. This has not been possible since the only available whole-body CBL-B knockout mice exhibit constitutive tumor rejection. We engineered a new CBL-B(flox/flox) mouse, combined this with an existing CBL(flox/flox) mouse to generate CBL(flox/flox); CBL-B(flox/flox) mice, and tested the tissue-specific concurrent deletion of CBL and CBL-B using the widely-used CD4-Cre transgenic allele to produce a T-cell-specific double knockout. Altered T-cell development, constitutive peripheral T-cell activation, and a lethal multi-organ immune infiltration phenotype largely resembling the previous Lck-Cre driven floxed-CBL deletion on a CBL-B knockout background establish the usefulness of the new model for tissue-specific CBL/CBL-B deletion. Unexpectedly, CD4-Cre-induced deletion in a small fraction of hematopoietic stem cells led to expansion of certain non-T-cell lineages, suggesting caution in the use of CD4-Cre for T-cell-restricted gene deletion. The establishment of a new model of concurrent tissue-selective CBL/CBL-B deletion should allow a clear assessment of the tumor-intrinsic roles of CBL/CBL-B in non-myeloid malignancies and help test the potential for CBL/CBL-B inactivation in immunotherapy of tumors. Impact Journals LLC 2016-06-03 /pmc/articles/PMC5239462/ /pubmed/27276677 http://dx.doi.org/10.18632/oncotarget.9812 Text en Copyright: © 2016 Goetz et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Goetz, Benjamin
An, Wei
Mohapatra, Bhopal
Zutshi, Neha
Iseka, Fany
Storck, Matthew D.
Meza, Jane
Sheinin, Yuri
Band, Vimla
Band, Hamid
A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title_full A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title_fullStr A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title_full_unstemmed A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title_short A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
title_sort novel cbl-b(flox/flox) mouse model allows tissue-selective fully conditional cbl/cbl-b double-knockout: cd4-cre mediated cbl/cbl-b deletion occurs in both t-cells and hematopoietic stem cells
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239462/
https://www.ncbi.nlm.nih.gov/pubmed/27276677
http://dx.doi.org/10.18632/oncotarget.9812
work_keys_str_mv AT goetzbenjamin anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT anwei anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT mohapatrabhopal anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT zutshineha anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT isekafany anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT storckmatthewd anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT mezajane anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT sheininyuri anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT bandvimla anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT bandhamid anovelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT goetzbenjamin novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT anwei novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT mohapatrabhopal novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT zutshineha novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT isekafany novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT storckmatthewd novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT mezajane novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT sheininyuri novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT bandvimla novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells
AT bandhamid novelcblbfloxfloxmousemodelallowstissueselectivefullyconditionalcblcblbdoubleknockoutcd4cremediatedcblcblbdeletionoccursinbothtcellsandhematopoieticstemcells